INNOVATIVE
SOLUTIONS FOR
INHALATION SAFETY
ImmuONE specialises in human alveolar macrophage responses and epithelial cell culture platforms

IN VITRO INNOVATION SERVICES
FOR EMPOWERED DECISION MAKING
ImmuONE provides innovative in vitro products and testing services for inhalation safety assessment using state-of-the-art techniques. Our specialist team of in vitro scientists can work with you to develop assays and endpoints for your translational and toxicity needs. We aim to take the work out of solution thinking with our innovations.
APPLICATIONS OF OUR
TESTING TOOLS
We are exploring the breadth of applications for our products and services to help you make better, earlier decisions for your future products and chemicals. Our highly experienced team completes the in-house testing services, and we are partnered with other laboratories to facilitate your study requests.
Pharma
Cosmetics
Chemical
Crop Protection
Environment
Consumer

IN VITRO CELL CULTURES
Our expertise covers the immune system, the lower airways of the lung and the creation of 3D lung in vitro models to help assess the effects of chemicals inhaled by humans and animals.

SERVICES
Our aim is to provide better toxicity analysis and design bespoke assays with our customers supporting them throughout the entire process

SHIPPING POSSIBILITIES
All shipping possibilities are discussed with our customers to make sure their needs are fulfilled
The story of ImmuONE
OUR LATEST NEWS AND PRESS RELEASES
Catching up with 21st century practices
Removing all animal derived products from in vitro cell culture.Foetal Bovine Serum (FBS) is a highly utilised serum supplement for biomedical research and in v ...
CRACK IT Challenge 36: Winners Phase 2
Following successful completion on the phase 1 challenge awarded to ImmuONE by the NC3Rs, we were announced as the winners for the phase 2 challenge in Jan 2022 ...
CRACK IT Challenge 36: Animal-free in vitro
We are excited to announce that ImmuONE was awarded funding to carry out the six-month proof-of-concept studies in Phase 1 of this year's CRACK IT Challenges co ...